Shefali Agarwal

(Dr. Shefali Agarwal)

Currently holds a position at Fate Therapeutics Inc

Positions

Position Company Period
Director Fate Therapeutics Inc July 15, 2019 -
Shefali Agarwal's trades of Fate Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-06-08 2022-06-07 S Sale
841 -31.4%
21.89
USD 18,409
841 -31.4% 21.89 USD 18,409
2022-06-06 2022-06-03 S Sale
807 -30.1%
22.80
USD 18,400
807 -30.1% 22.80 USD 18,400
2022-02-09 2022-02-07 PS Planned sale
1,058 -0.7%
1.50
USD 1,587
1,058 -0.7% 1.50 USD 1,587
2022-02-04 2022-02-02 PS Planned sale
2,639 -1.6%
1.37
USD 3,615
2,639 -1.6% 1.37 USD 3,615
2022-01-28 2022-01-26 PS Planned sale
2,922 -1.8%
2.02
USD 5,902
2,922 -1.8% 2.02 USD 5,902
2021-12-07 2021-12-06 PS Planned sale
1,780 -1.1%
2.93
USD 5,215
1,780 -1.1% 2.93 USD 5,215
2021-02-05 2021-02-04 PS Planned sale
969 -0.9%
11.21
USD 10,862
969 -0.9% 11.21 USD 10,862
2021-01-27 2021-01-25 PS Planned sale
2,872 -3.7%
11.41
USD 32,770
2,872 -3.7% 11.41 USD 32,770
2020-12-07 2020-12-03 PS Planned sale
2,522 -3.2%
13.54
USD 34,148
2,522 -3.2% 13.54 USD 34,148
2020-03-26 2020-03-25 PS Planned sale
1,243 -1.7%
15.28
USD 18,993
1,243 -1.7% 15.28 USD 18,993
2020-01-27 2020-01-27 PS Planned sale
2,630 -4.3%
20.44
USD 53,757
2,630 -4.3% 20.44 USD 53,757
2020-01-27 2020-01-24 PS Planned sale
1,843 -2.9%
24.64
USD 45,412
1,843 -2.9% 24.64 USD 45,412
2019-06-17 2019-06-14 PS Planned sale
1,195 -3.2%
11.97
USD 14,304
1,195 -3.2% 11.97 USD 14,304
// ... existing code ... // ... rest of the file ...